Dexcom

DexCom and Tandem Diabetes Care have a CGM Development and Commercialization Agreement to integrate the Dexcom's future generation sensor into the t:slim Insulin Delivery System. The t:slim, the first touch-screen insulin pump, has FDA approval but is not on the market yet. The announcement also mentions "future generations of the sensor", so it may be awhile before we see the systems actually working together.

Dexcom is making more friends. Already having partnerships with Animas and Omnipod, Dexcom has now signed a research and development agreement with Roche Diagnostics U.S. The plan is to integrate Dexcom's continuous glucose monitor into Roche's insulin pumps so you can see trends and blood glucose data in one handheld device.

Here's an excerpt from the announcement:

OUTDATED Dexcom - Transdermal Glucose Oxidase Enzyme. Please visit our Dexcom Info page.

A continuous monitor reveals short-term trends in the blood sugar as they happen. You can see the direction your blood sugar is taking in the last 1, 3, 6, 9, 12, or 24 hours, depending on what times the monitor offers. Various companies have already released continuous monitors, with more companies developing theirs every day.

Diabetes care has improved with many of the technological advances in the field. From improvements in insulin pumps and infusion sets to the implementation of continuous glucose monitors, technology is helping deal with diabetes easier than ever before. More technology companies are getting involved in diabetes everyday. In this section, you will find information on: